Comparison of serum levels of IL-6, IL-8, TNF-α, C reactive protein and heat shock protein 70 in patients with active or inactive Behçet's disease

Turkish Journal of Medical Sciences

Volumn 40, Issue 1, 2010, Pages 57-62

  Karadaǧ, Remzi ^a   Koca, Cemile ^a   Totan, Yüksel ^a   Yaǧci, Ramazan ^a   Aydin, Murat ^a   Karadaǧ, Ayşe Serap ^b   Akbay, Gülfer ^c   Ekşioǧlu, Meral ^c   Yiǧitoǧlu, Ramazan ^a  

^a FATIH UNIVERSITY   (Turkey)

^b Keçiören Training and Research Hospital ^*  (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Beh et's disease; C reactive protein; Chemokine; Cytokine; Heat shock protein; Interleukin

Indexed keywords

C-REACTIVE PROTEINS; CHEMOKINES; CONTROL GROUPS; CYTOKINES; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; IN-CONTROL; INACTIVE PHASE; SERUM LEVELS; STUDY GROUPS;

BODY FLUIDS; GENE EXPRESSION; PROTEINS;

DISEASE CONTROL;

C REACTIVE PROTEIN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHCET DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 76149122127     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-0906-3     Document Type: Article

References (30)

1. Zierhut M, Mizuki N, Ohno S, Inoko H, Gül A, Onoé K et al. Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci 2003; 60: 1903-22.
2. Lehner T, Adinolfi M. Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome. J Clin Pathol 1980; 33: 269-75.
3. Bardak Y, Aridogan BC. The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement. Ocul Immunol Inflamm 2004; 12: 53-58.
4. Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002; 11: 87-93.
5. Akdeniz N, Esrefoglu M, Keleş MS, Karakuzu A, Atasoy M. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore 2004; 33: 596-9.
6. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroǧlu IC, Dündar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol 1996; 23: 321-2.
7. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 2003; 21(4 Suppl 30): S44-8.
8. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet 2003; 362: 469-76.
9. Murray PJ, Young RA. Stress and immunological recognition in host-pathogen interactions. J Bacteriol 1992; 174: 4193-6.
10. Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-36.
11. Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 2001; 60: 996-1002.
12. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12: 1539-46.
13. Kitamei H, Kitaichi N, Yoshida K, Nakai A, Fujimoto M, Kitamura M et al. Association of heat shock protein 70 induction and the amelioration of experimental autoimmune uveoretinitis in mice. Immunobiology 2007; 212: 11-8.
14. Yanaka A, Zhang S, Sato D, Tauchi M, Suzuki H, Shibahara T et al. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70. Digestion 2007; 75: 148-55.
15. Zheng Z, Kim JY, Ma H, Lee JE, Yenari MA. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J Cereb Blood Flow Metab 2008; 28: 53-63.
16. Malago JJ, Koninkx JF, Tooten PC, van Liere EA, van Dijk JE. Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. Clin Exp Immunol 2005; 141: 62-71.
17. Luo X, Zuo X, Zhou Y, Zhang B, Shi Y, Liu M et al. Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes. Arthritis Res Ther 2008; 10: R41.
18. Moseley PL. Heat shock proteins and the inflammatory response. Ann N Y Acad Sci 1998; 856: 206-13.
19. Todryk SM, Gough MJ, Pockley AG. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology 2003; 110: 1-9.
20. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
21. Gürbüz O, Ozdemir Y, Coşar CB, Kural G. Lipoprotein (a) in Behçet's disease as an indicator of disease activity and in thrombotic complications. Eur J Ophthalmol 2001; 11: 62-5.
22. Müftüoǧlu AU, Yazici H, Yurdakul S, Tüzün Y, Pazarli H, Güngen G et al. Behçet's disease. Relation of serum C reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986; 25: 235-9.
23. Bodur H, Borman P, Ozdemir Y, Atan C, Kural G. Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity. Clin Rheumatol 2006; 25: 329-33.
24. Pay S, Simşek I, Erdem H, Dinç A. Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007; 27: 417-24.
25. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992; 62: 60-5.
26. al-Dalaan A, al-Sedairy S, al-Balaa S, al-Janadi M, Elramahi K, Bahabri S et al. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995; 22: 904-7.
27. Luscinskas FW, Kiely JM, Ding H, Obin MS, Hébert CA, Baker JB et al. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 1992; 149: 2163-71.
28. Sahin S, Akoǧlu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996; 55: 128-33.
29. Balkwill FR. Tumour necrosis factor. Br Med Bull 1989; 45: 389-400.
30. de Smet MD, Ramadan A. Circulating antibodies to inducible heat shock protein 70 in patients with uveitis. Ocul Immunol Inflamm 2001; 9: 85-92.